- Home
- CLOV
as 10-20-2025 3:53pm EST
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | JERSEY CITY |
| Market Cap: | 1.3B | IPO Year: | N/A |
| Target Price: | $4.37 | AVG Volume (30 days): | 10.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.12 - $4.87 | Next Earning Date: | 11-04-2025 |
| Revenue: | $1,607,900,000 | Revenue Growth: | 22.12% |
| Revenue Growth (this year): | 39.93% | Revenue Growth (next year): | 28.94% |
Stock Insider Trading Activity of Clover Health Investments Corp. (CLOV)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Oct 7 '25 | Sell | $2.65 | 2,012 | $5,331.80 | 3,043,172 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Sep 17 '25 | Sell | $3.09 | 4,914 | $15,184.26 | 3,043,172 | |
| Loengard Anna U | CLOV | N/A | Aug 13 '25 | Buy | $2.59 | 26,500 | $68,755.00 | 27,600 |
Latest Clover Health Investments Corp. News
CLOV Breaking Stock News: Dive into CLOV Ticker-Specific Updates for Smart Investing
Simply Wall St.
6 days ago
Clover Health (CLOV): Assessing Valuation as Shares Show Modest Recovery
Simply Wall St.
6 days ago
How Recent Developments Are Shaping the Story Behind Clover Health Investments
GlobeNewswire
6 days ago
Clover Health’s 2026 Medicare Advantage Plans Champion Affordability and Choice
StockStory
6 days ago
2 Unprofitable Stocks to Target This Week and 1 Facing Challenges
GlobeNewswire
7 days ago
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
StockStory
a month ago
Why Clover Health (CLOV) Stock Is Trading Up Today
Simply Wall St.
a month ago
The Bull Case For Clover Health (CLOV) Could Change Following CEO’s Testimony on AI-Driven Care
GlobeNewswire
2 months ago
Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way
Compare CLOV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLOV Clover Health Investments Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.